Potential drug for Ebola on trial in Liberia

A trial of a potential drug to treat Ebola has started at the Medecins Sans Frontieres centre in Liberia.

The drug, antiviral-brincidofovir is being tested on Ebola patients on a voluntary basis.

People who do not consent to it receive standard care. 

Oxford University scientists leading the research say initial results are expected in the next few months.

A study involving a similar drug - favipiravir, began in Guinea in December last year.

While a handful of experimental drugs, including brincidofovir and favipiravir, have been given on a compassionate basis in the last year, none has yet been proven to work against the virus in scientific human trials.

SOURCE: BBC